Trial Details
TERMINATEDBasic Information
| Clinical ID | c3073 |
|---|---|
| Identifier | NCT02559817 |
| Trial Title | A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation |
| Interventions | DRUG: Linaclotide Dose A|DRUG: Linaclotide Dose B|DRUG: Linaclotide Dose C|DRUG: Linaclotide Approved Adult Dose|DRUG: Matching Placebo |
Participant Information
| Sponsor | Forest Laboratories |
|---|---|
| City | Hot Springs |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-11-01 |
|---|---|
| Primary Completion Date | 2019-08-30 |
| Completion Date | 2019-08-30 |